Create a narrative

Lotus Pharmaceutical Community

TWSE:1795 Community

1 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

Create a narrative

Lotus Pharmaceutical

AN

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

Alpha Choay Acquisition And New R&D Center Will Strengthen Southeast Asia Presence

Key Takeaways Strategic acquisitions and alliances are bolstering Lotus Pharmaceutical's growth and diversification, particularly in Southeast Asia. In-house production and a strong product pipeline are enhancing profitability and driving revenue and earnings growth.

NT$368.00

FV

39.3% undervalued

7.05%

Revenue growth p.a.

0

0

1

5 days ago